Deferoxamine Injection and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Deferoxamine Injection and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferoxamine
Brand name: Desferal
Synonyms: Deferoxamine
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferoxamine Injection-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Deferoxamine Injection-Kitabis Pak
- Deferoxamine Injection-Kitabis Pak inhalation
- Deferoxamine Injection-Klofensaid II
- Deferoxamine Injection-Klonopin
- Deferoxamine Injection-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Deferoxamine Mesylate
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Defibrotide
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Defibrotide Intravenous
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Defibrotide Sodium
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Definity
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Defitelio